Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Why Cal-Maine Foods Shares Are Trading Lower; Here Are 24 Stocks Moving Premarket

Published 29/12/2022, 11:36
Updated 29/12/2022, 12:40
© Reuters.  Why Cal-Maine Foods Shares Are Trading Lower; Here Are 24 Stocks Moving Premarket

Benzinga - Gainers

  • Quotient Limited (NASDAQ: QTNT) shares rose 125% to $0.54 in pre-market trading after dropping around 38% on Wednesday. Quotient recently announced the intent to voluntary delist from the Nasdaq Global Market.
  • Esports Entertainment Group, Inc. (NASDAQ: GMBL) rose 62.2% to $0.1281 in pre-market trading after declining over 10% on Wednesday. Esports Entertainment Group recently named Alex Igelman as Chief Executive Officer.
  • Baudax Bio, Inc. (NASDAQ: BXRX) shares rose 37.4% to $3.16 in pre-market trading after gaining over 5% on Wednesday. Baudax Bio recently announced initiation of a Phase II clinical trial evaluationg BX1000 in patients undergoing surgery.
  • AEye, Inc. (NASDAQ: LIDR) rose 28% to $0.64 in pre-market trading. AEye recently promoted T.R. Ramachandran to Chief Operating Officer.
  • Elys Game Technology, Corp. (NASDAQ: ELYS) rose 22.5% to $0.3184 in pre-market trading after dropping around 30% on Wednesday. Elys Game Technology and Cloakbook were recently granted a license to commence sportsbook operations in Washington, D.C.
  • Helbiz, Inc. (NASDAQ: HLBZ) rose 19.6% to $0.1366 in pre-market trading after dropping around 9% on Wednesday.
  • Kala Pharmaceuticals, Inc. (NASDAQ: KALA) rose 16.5% to $14.54 in pre-market trading. Kala Pharmaceuticals shares jumped 218% on Wednesday after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal epithelial defect.
  • VistaGen Therapeutics, Inc.. (NASDAQ: VTGN) rose 15.3% to $0.1049 in pre-market trading. Vistagen Therapeutics recently agreed to acquire Pherin Pharmaceuticals Inc in an all-stock transaction of approximately 12.4 million shares.
  • Nuwellis, Inc. (NASDAQ: NUWE) rose 13.4% to $10.40 in pre-market trading. Nuwellis recently announced compliance with Nasdaq listing requirements.
  • Hyzon Motors Inc. (NASDAQ: HYZN) shares rose 12.9% to $1.58 in pre-market trading after the company announced it entered into an equity capital contribution agreement last week with Chevron (NYSE:CVX) New Energies, a division of Chevron’s U.S. business, and Raven SR.
  • Smart for Life, Inc. (NASDAQ: SMFL) rose 11.8% to $0.26 in pre-market trading. Smart For Life recently announced the launch of Greens First Protein Bars.
  • TG Therapeutics, Inc. (NASDAQ: TGTX) rose 9.1% to $9.23 in pre-market trading. TG Therapeutics shares gained 8% on Wednesday following FDA approval of ublituximab.
  • HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) rose 8.8% to $3.84 in pre-market trading after dropping 18% on Wednesday. HTG Molecular Diagnostics recently announced the closing of a $10 million offering.
  • Mullen Automotive, Inc. (NASDAQ: MULN) rose 8.4% to $0.23 in pre-market trading. Mullen Automotive recently announced its I-GO Commercial Urban Delivery EV has arrived Europe.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Losers
  • Argo Blockchain plc (NASDAQ: ARBK) shares fell 14.8% to $0.6251 in pre-market trading. Argo Blockchain shares gained 36% on Wednesday after the company entered into definitive agreements with Galaxy Digital Holdings, under which an Argo subsidiary will sell its Helios facility in Dickens County, Texas for $65 million.
  • Minerva Surgical, Inc. (NASDAQ: UTRS) fell 14.4% to $0.2310 in pre-market trading. Minerva Surgical shares climbed 66% on Wednesday after the company announced a $30 million private placement of common stock led by Accelmed Partners.
  • TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell 10.5% to $0.5460 in pre-market trading after jumping around 52% on Wednesday.
  • Gaotu Techedu Inc. (NASDAQ: GOTU) fell 10.3% to $2.54 in pre-market trading after dropping 14% on Wednesday.
  • Unicycive Therapeutics, Inc. (NASDAQ: UNCY) fell 10% to $0.45 in pre-market trading after dropping 25% on Wednesday. The company’s pivotal bioequivalence (BE) study comparing Renazorb to Fosrenol met the primary endpoint.
  • Ambrx Biopharma Inc. (NYSE: AMAM) shares fell 9% to $1.41 in pre-market trading after declining around 8% on Wednesday.
  • IsoPlexis Corporation (NASDAQ: ISO) fell 8.3% to $1.43 in pre-market trading. Berkeley Lights recently announced plans to acquire the company for $57.8 million.
  • PureCycle Technologies, Inc. (NASDAQ: PCT) fell 6.4% to $6.00 in pre-market trading.
  • TAL Education Group (NYSE: TAL) fell 5.1% to $7.13 in pre-market trading after dropping around 15% on Wednesday.
  • Cal-Maine Foods, Inc. (NASDAQ: CALM) fell 3.5% to $60.00 in pre-market trading. Cal-Maine Foods reported downbeat earnings for its second quarter, while sales topped expectations.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.